Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS
Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. Methods For the study, 52 fem...
Saved in:
Published in | Journal of human nutrition and dietetics Vol. 37; no. 1; pp. 5 - 17 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.02.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 0952-3871 1365-277X 1365-277X |
DOI | 10.1111/jhn.13194 |
Cover
Abstract | Background
The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.
Methods
For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.
Results
At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).
Conclusions
A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.
When symptoms worsen, it may be advised to follow a low‐fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet for 2–8 weeks before gradually reintroducing the person to their regular eating routine. To prevent long‐term nutrient deficits, it is important to monitor energy and nutrient intakes during the diet under the direction of a nutritionist.
Highlights
A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside.
It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term.
Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake.
FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota. |
---|---|
AbstractList | The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.BACKGROUNDThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.METHODSFor the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).RESULTSAt the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).A low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype.CONCLUSIONSA low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low-FODMAP diet was given to the first group and a low-FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three-day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check-in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS-QOL) and IBS Symptom Severity Score (IBS-SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS-SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS-QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). A low-FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. Background The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. Methods For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. Results At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). Conclusions A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. When symptoms worsen, it may be advised to follow a low‐fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet for 2–8 weeks before gradually reintroducing the person to their regular eating routine. To prevent long‐term nutrient deficits, it is important to monitor energy and nutrient intakes during the diet under the direction of a nutritionist. Highlights A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside. It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term. Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake. FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota. BACKGROUND: The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS. METHODS: For the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities. RESULTS: At the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05). CONCLUSIONS: A low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. BackgroundThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women diagnosed with IBS.MethodsFor the study, 52 female IBS patients between the ages of 20 and 55 were enrolled. Individuals were monitored for 6 weeks in two groups. A low‐FODMAP diet was given to the first group and a low‐FODMAP diet plus a probiotic supplement was given to the second group (Lactobacillus rhamnosus). Three‐day food intake records were kept at the start of the study and continued up to its conclusion, with a weekly check‐in in between. At the start and end of the trial, participants completed the Hospital Anxiety and Depression Scale, IBS Quality of Life Scale (IBS‐QOL) and IBS Symptom Severity Score (IBS‐SSS). The Bristol Stool Scale was also used by the subjects to record their daily stool densities.ResultsAt the end of the study, it was determined that the daily intake of FODMAP (lactose [g] + oligosaccharides [g] + mannitol [g] + sorbitol [g]) decreased significantly in both groups (p < 0.05). At the end of the study, it was determined that the IBS‐SSS, anxiety and depression scores of the individuals in both groups decreased significantly and their IBS‐QOL scores increased significantly (p < 0.05). However, the difference between these values between the groups was not statistically significant (p > 0.05).ConclusionsA low‐FODMAP diet has been demonstrated to benefit people by lessening the severity of their IBS symptoms and enhancing their quality of life. No evidence was found, however, to indicate that the FODMAP diet would be more beneficial on these metrics if additional probiotics were used. It should be emphasised that the reaction of probiotic strains may vary depending on the IBS subtype. A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe, gradually transitioning the individual to the normal nutrition process when symptoms subside. It is necessary to follow up the energy and nutrient intakes according to individual characteristics during the diet under the guidance of a dietitian to prevent nutrient deficiencies in the long term. Patients should be given dietary advice on choosing high‐fibre, low‐FODMAP‐sourced fruits, vegetables and grains to balance their daily fibre intake. FODMAP restriction reduces the intake of prebiotics, which affects the gastrointestinal microbiota. |
Author | Yıldırım, Abdullah Emre Tek, Nilüfer Acar Ustaoğlu, Tuba |
Author_xml | – sequence: 1 givenname: Tuba orcidid: 0000-0003-1137-0368 surname: Ustaoğlu fullname: Ustaoğlu, Tuba email: tuba.ustaoglu@sanko.edu.tr organization: SANKO University – sequence: 2 givenname: Nilüfer Acar orcidid: 0000-0002-8772-9608 surname: Tek fullname: Tek, Nilüfer Acar organization: Gazi University – sequence: 3 givenname: Abdullah Emre orcidid: 0000-0002-4386-9297 surname: Yıldırım fullname: Yıldırım, Abdullah Emre organization: Memorial Bahçelievler Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37430435$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9qFDEUxoNU7LZ64QtIwJsWnDb_ZjJzWWtrK9UKKngXMskZNsvMZJtkXPZNfFyz3d2bopiLhAO_7wvnnO8IHYx-BIReU3JG8zlfzMczymkjnqEZ5VVZMCl_HqAZaUpW8FrSQ3QU44IQUlFCXqBDLgUngpcz9Pvql-4nnZwfse9wmgOGrgOT4r68vv_w-eIrtg4S1qPFy-Bb55MzmRixC8El3faAW7-CHsf1aIMfAJ_cvv92msthmfwQ3-GHSfcurTeuvevg0crCMkCMm7_diFdZlm-X5jhrX6Lnne4jvNq9x-jH9dX3y5vi7v7j7eXFXWF4XYlCUktrWdKyJpYaKSvaSFqDqVhNDOO2BNEI3mpKKBdWSmMqKw3nYAiBmjT8GJ1sfXNfDxPEpAYXDfS9HsFPUeU5EV5RxsR_UVaXQjAhRZXRt0_QhZ_CmBtRrKGSEU6IzNSbHTW1A1i1DG7QYa3268nA-RYwwccYoFMmT3uzrBS06xUlahMAlQOgHgOQFadPFHvTv7E795XrYf1vUH26-bJV_AG6l7zd |
CitedBy_id | crossref_primary_10_1007_s10620_024_08671_8 crossref_primary_10_1134_S2635167624602092 crossref_primary_10_3390_nu16203515 crossref_primary_10_3390_foods13152386 crossref_primary_10_59778_sbfdergisi_1475334 |
Cites_doi | 10.1016/j.cgh.2017.06.044 10.1111/j.1742-1241.2004.00377.x 10.1016/j.jand.2019.01.017 10.1016/j.jada.2006.07.010 10.1023/A:1018831127942 10.1186/s42506-019-0023-8 10.1016/j.genm.2009.03.004 10.3748/wjg.v20.i10.2456 10.1017/S0029665116000021 10.1053/j.gastro.2016.02.032 10.1017/S0033291796004382 10.3748/wjg.v23.i21.3771 10.1046/j.1365-2036.1997.142318000.x 10.3390/nu11071566 10.3748/wjg.v20.i43.16215 10.1159/000051878 10.1053/j.gastro.2013.09.046 10.14309/00000434-200901001-00002 10.1177/14732300080360S101 10.1097/MCG.0b013e318247157c 10.3748/wjg.v20.i34.12144 10.1111/nmo.13154 10.1097/MOG.0000000000000158 10.3390/foods7020013 10.3748/wjg.v23.i25.4632 10.1007/s00394-021-02620-1 10.1007/s00394-019-02074-6 10.3920/BM2017.0105 10.1016/S1590-8658(00)80021-3 10.3109/00365529709011203 10.1053/j.gastro.2015.07.054 10.1016/j.cgh.2012.02.029 10.1111/j.1365-277X.2011.01162.x 10.1136/gutjnl-2014-307264 10.1016/j.amjmed.2015.01.036 |
ContentType | Journal Article |
Copyright | 2023 British Dietetic Association. 2024 The British Dietetic Association Ltd. |
Copyright_xml | – notice: 2023 British Dietetic Association. – notice: 2024 The British Dietetic Association Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T7 8FD C1K FR3 NAPCQ P64 7X8 7S9 L.6 |
DOI | 10.1111/jhn.13194 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Engineering Research Database Technology Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA Nursing & Allied Health Premium CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Diet & Clinical Nutrition |
EISSN | 1365-277X |
EndPage | 17 |
ExternalDocumentID | 37430435 10_1111_jhn_13194 JHN13194 |
Genre | article Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Responsible investigator, T.U. |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHBH AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABDPE ABEML ABFSI ABIVO ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AI. AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO E.L EBS EJD EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ PZZ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K VH1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~KM ~WT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T7 8FD C1K FR3 NAPCQ P64 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c3864-71d18751580d1c77619718ec6280c23d5e4943ba10134d77cc6d7c33ec00e8093 |
IEDL.DBID | DR2 |
ISSN | 0952-3871 1365-277X |
IngestDate | Fri Sep 05 17:20:17 EDT 2025 Fri Sep 05 08:15:38 EDT 2025 Fri Jul 25 23:28:08 EDT 2025 Mon Jul 21 05:55:24 EDT 2025 Thu Apr 24 23:09:11 EDT 2025 Sun Aug 24 04:57:33 EDT 2025 Sun Jul 06 04:45:15 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | probiotic IBS symptom severity depression quality of life irritable bowel syndrome FODMAP diet |
Language | English |
License | 2023 British Dietetic Association. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3864-71d18751580d1c77619718ec6280c23d5e4943ba10134d77cc6d7c33ec00e8093 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0003-1137-0368 0000-0002-8772-9608 0000-0002-4386-9297 |
PMID | 37430435 |
PQID | 2917203007 |
PQPubID | 35966 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_3040361224 proquest_miscellaneous_2854424746 proquest_journals_2917203007 pubmed_primary_37430435 crossref_citationtrail_10_1111_jhn_13194 crossref_primary_10_1111_jhn_13194 wiley_primary_10_1111_jhn_13194_JHN13194 |
PublicationCentury | 2000 |
PublicationDate | February 2024 2024-02-00 20240201 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: February 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Journal of human nutrition and dietetics |
PublicationTitleAlternate | J Hum Nutr Diet |
PublicationYear | 2024 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2015; 19 2019; 94 2015; 149 2020; 120 2019; 11 2015; 31 2017; 23 2008; 36 2003; 14 2016; 75 2006; 5 2020; 59 1997; 27 2015; 128 2007; 31 1998; 43 2012; 10 2016; 14 2001; 63 2014; 20 1997; 8 2018; 7 2004; 10 2018; 9 2016; 2 1997; 11 2017; 15 1997; 32 2015; 64 2000; 32 2016; 20 2018 2011; 24 2018; 30 2016 2009; 6 2014; 18 2005; 59 2012; 46 2021; 60 2006; 106 2009; 104 2016; 9 2010; 9 2016; 150 2014; 146 Uran B (e_1_2_11_25_1) 2016; 2 e_1_2_11_30_1 e_1_2_11_36_1 Aydemir O (e_1_2_11_26_1) 1997; 8 e_1_2_11_51_1 e_1_2_11_13_1 e_1_2_11_11_1 e_1_2_11_29_1 Watkins AM (e_1_2_11_39_1) 2016; 14 e_1_2_11_6_1 e_1_2_11_4_1 e_1_2_11_48_1 Özden A (e_1_2_11_32_1) 2006; 5 e_1_2_11_45_1 e_1_2_11_47_1 Cuomo R (e_1_2_11_14_1) 2014; 20 e_1_2_11_24_1 e_1_2_11_41_1 Pekcan AG (e_1_2_11_43_1) 2016 e_1_2_11_22_1 e_1_2_11_17_1 Nanayakkara WS (e_1_2_11_16_1) 2016; 9 e_1_2_11_38_1 e_1_2_11_19_1 Hacıhasanoğlu R (e_1_2_11_27_1) 2010; 9 e_1_2_11_50_1 e_1_2_11_10_1 e_1_2_11_31_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_33_1 e_1_2_11_7_1 Kaya M (e_1_2_11_8_1) 2016; 20 e_1_2_11_28_1 e_1_2_11_3_1 e_1_2_11_49_1 Barrett JS (e_1_2_11_15_1) 2007; 31 Mulak A (e_1_2_11_34_1) 2004; 10 Güray C (e_1_2_11_2_1) 2015; 19 Karaman N (e_1_2_11_5_1) 2003; 14 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_46_1 e_1_2_11_40_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_18_1 e_1_2_11_37_1 Sezer E (e_1_2_11_20_1) 2014; 18 |
References_xml | – volume: 150 start-page: 1262 year: 2016 end-page: 79 article-title: Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV publication-title: Gastroenterology – volume: 20 start-page: 398 year: 2016 end-page: 400 article-title: Roma IV kriterlerine göre fonksiyonel barsak hastalıklarının yeniden değerlendirilmesi publication-title: GG – volume: 128 start-page: 817 year: 2015 end-page: 27 article-title: Irritable bowel syndrome: modern concepts and management options publication-title: Am J Med – volume: 30 year: 2018 article-title: Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome publication-title: Neurogastroenterol Motil – volume: 14 start-page: 128 year: 2003 end-page: 31 article-title: Irritable bowel syndrome prevalence in city center of Sivas publication-title: The Turkish J Gastroenterol – volume: 31 start-page: 51 year: 2007 article-title: Clinical ramifications of malabsorption of fructose and other short‐chain carbohydrates publication-title: Practical Gastroenterol – volume: 5 start-page: 4 year: 2006 end-page: 15 article-title: Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı publication-title: Akademik Gastroenteroloji – volume: 59 start-page: 2237 year: 2020 end-page: 48 article-title: Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study publication-title: Eur J Nutr – start-page: 27 year: 2018 end-page: 59 – volume: 15 start-page: 1890 year: 2017 end-page: 9 article-title: A diet low in fermentable oligo‐, di‐, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea publication-title: Clin Gastroenterol Hepatol – volume: 9 start-page: 697 year: 2018 end-page: 706 article-title: CL1285, LBC80R and CLR2 improve quality‐of‐life and IBS symptoms: a double‐blind, randomised, placebo‐controlled study publication-title: Benef Microbes – volume: 8 start-page: 280 year: 1997 end-page: 7 article-title: Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlilik ve Güvenilirlik Çalışması. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale publication-title: Turk psikiyatri dergisi – volume: 18 start-page: 174 year: 2014 end-page: 9 article-title: İrritabl bağırsak sendromunun tedavisinde prebiyotik ve probiyotik kullanımı publication-title: GG – volume: 11 start-page: 395 year: 1997 end-page: 402 article-title: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress publication-title: Aliment Pharmacol Ther – volume: 20 start-page: 8837 year: 2014 end-page: 45 article-title: Irritable bowel syndrome and food interaction publication-title: World J Gastroenterol – volume: 19 start-page: 172 year: 2015 article-title: İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar publication-title: Güncel Gastroenteroloji – volume: 2 start-page: 2 year: 2016 article-title: Psychometric properties of the irritable bowel syndrome quality of life scale in Turkey publication-title: J Hepatol Gastroint Dis – volume: 149 start-page: 1399 year: 2015 end-page: 407 article-title: Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial publication-title: Gastroenterology – volume: 10 start-page: 712 year: 2012 end-page: 21 article-title: Global prevalence of and risk factors for irritable bowel syndrome: a meta‐analysis publication-title: Clin Gastroenterol Hepatol – volume: 146 start-page: 67 year: 2014 end-page: 75 article-title: A diet low in FODMAPs reduces symptoms of irritable bowel syndrome publication-title: Gastroenterology – volume: 9 start-page: 209 year: 2010 end-page: 16 article-title: Bir sağlık ocağına başvuran kronik hastalığı olan bireylerde anksiyete ve depresyon publication-title: TAF Prev Med Bull – volume: 63 start-page: 108 year: 2001 end-page: 15 article-title: Food‐related gastrointestinal symptoms in the irritable bowel syndrome publication-title: Digestion – volume: 23 start-page: 3771 year: 2017 end-page: 83 article-title: Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients! publication-title: World J Gastroenterol – volume: 106 start-page: 1631 year: 2006 end-page: 9 article-title: Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management publication-title: J Am Diet Assoc – volume: 11 start-page: 1566 year: 2019 article-title: Effect of three diets (low‐FODMAP, gluten‐free and balanced) on irritable bowel syndrome symptoms and health‐related quality of life publication-title: Nutrients – start-page: 29 year: 2016 end-page: 45 – volume: 31 start-page: 166 year: 2015 end-page: 71 article-title: Diet and irritable bowel syndrome publication-title: Curr Opin Gastroenterol – volume: 20 start-page: 12144 year: 2014 end-page: 60 article-title: Irritable bowel syndrome: a clinical review publication-title: World J Gastroenterol – volume: 32 start-page: 920 year: 1997 end-page: 4 article-title: Stool form scale as a useful guide to intestinal transit time publication-title: Scand J Gastroenterol – volume: 120 start-page: 535 year: 2020 end-page: 47 article-title: Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet publication-title: J Acad Nutr Diet – volume: 32 start-page: 294 year: 2000 end-page: 301 article-title: Bacterial supplementation in the irritable bowel syndrome. A randomised doubleblind placebo‐controlled crossover study publication-title: Dig Liver Dis – volume: 59 start-page: 361 issue: 3 year: 2005 end-page: 9 article-title: The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community‐based study publication-title: Int J Clin Pract – volume: 14 start-page: 9 year: 2016 end-page: 17 article-title: Is the restriction of Fermentable Short Chain Carbohydrate (FODMAP) a credible solution for the Irritable Bowel Syndrome patient? publication-title: S Afr Gastroenterol Rev – volume: 64 start-page: 93 year: 2015 end-page: 100 article-title: Diets that differ in their FODMAP content alter the colonic luminal microenvironment publication-title: Gut – volume: 43 start-page: 400 year: 1998 end-page: 11 article-title: Quality of life in persons with irritable bowel syndrome (development and validation of a new measure) publication-title: Dig Dis Sci – volume: 10 start-page: RA55 year: 2004 end-page: 62 article-title: Irritable bowel syndrome: a model of the brain‐gut interactions publication-title: Med Sci Monit – volume: 94 start-page: 23 year: 2019 article-title: Factors associated with irritable bowel syndrome among medical students at Ain Shams University publication-title: J Egypt Public Health Assoc – volume: 75 start-page: 306 year: 2016 end-page: 18 article-title: Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet publication-title: Proc Nutr Soc – volume: 9 start-page: 131 year: 2016 article-title: Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date publication-title: Clin Exp Gastroenterol – volume: 24 start-page: 487 year: 2011 end-page: 95 article-title: Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome: IBS symptom response to a low FODMAP diet publication-title: J Hum Nutr Diet – volume: 104 start-page: 1 year: 2009 end-page: 35 article-title: An evidence‐based position statement on the management of irritable bowel syndrome publication-title: Am J Gastroenterol – volume: 20 start-page: 8886 year: 2014 end-page: 97 article-title: Intestinal microbiota in pathophysiology and management of irritable bowel syndrome publication-title: World J Gastroenterol – volume: 7 start-page: 13 issue: 2 year: 2018 article-title: The role of bacteria, probiotics and diet in irritable bowel syndrome publication-title: Foods – volume: 20 start-page: 16215 year: 2014 end-page: 26 article-title: Ehealth: low FODMAP diet vs GG in irritable bowel syndrome publication-title: World J Gastroenterol – volume: 46 start-page: 356 year: 2012 end-page: 66 article-title: A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome publication-title: J Clin Gastroenterol – volume: 6 start-page: 152 year: 2009 end-page: 67 article-title: Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? publication-title: Gend Med – volume: 36 start-page: 1A year: 2008 end-page: 53 article-title: Probiotics in clinical practice: an overview publication-title: J Int Med Res – volume: 23 start-page: 4632 year: 2017 article-title: Long‐term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs publication-title: World J Gastroenterol – volume: 27 start-page: 363 year: 1997 end-page: 70 article-title: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects publication-title: Psychol Med – volume: 60 start-page: 3523 year: 2021 end-page: 3 article-title: Correction to: efficacy of a low‐FODMAP diet in adult irritable bowel syndrome: a systematic review and meta‐analysis publication-title: Eur J Nutr – ident: e_1_2_11_36_1 doi: 10.1016/j.cgh.2017.06.044 – ident: e_1_2_11_31_1 doi: 10.1111/j.1742-1241.2004.00377.x – ident: e_1_2_11_37_1 doi: 10.1016/j.jand.2019.01.017 – ident: e_1_2_11_40_1 – volume: 10 start-page: RA55 year: 2004 ident: e_1_2_11_34_1 article-title: Irritable bowel syndrome: a model of the brain‐gut interactions publication-title: Med Sci Monit – ident: e_1_2_11_18_1 doi: 10.1016/j.jada.2006.07.010 – ident: e_1_2_11_24_1 doi: 10.1023/A:1018831127942 – volume: 14 start-page: 128 year: 2003 ident: e_1_2_11_5_1 article-title: Irritable bowel syndrome prevalence in city center of Sivas publication-title: The Turkish J Gastroenterol – ident: e_1_2_11_30_1 doi: 10.1186/s42506-019-0023-8 – ident: e_1_2_11_33_1 doi: 10.1016/j.genm.2009.03.004 – volume: 14 start-page: 9 year: 2016 ident: e_1_2_11_39_1 article-title: Is the restriction of Fermentable Short Chain Carbohydrate (FODMAP) a credible solution for the Irritable Bowel Syndrome patient? publication-title: S Afr Gastroenterol Rev – ident: e_1_2_11_7_1 doi: 10.3748/wjg.v20.i10.2456 – ident: e_1_2_11_10_1 doi: 10.1017/S0029665116000021 – ident: e_1_2_11_9_1 doi: 10.1053/j.gastro.2016.02.032 – ident: e_1_2_11_28_1 doi: 10.1017/S0033291796004382 – ident: e_1_2_11_44_1 doi: 10.3748/wjg.v23.i21.3771 – volume: 9 start-page: 209 year: 2010 ident: e_1_2_11_27_1 article-title: Bir sağlık ocağına başvuran kronik hastalığı olan bireylerde anksiyete ve depresyon publication-title: TAF Prev Med Bull – ident: e_1_2_11_23_1 doi: 10.1046/j.1365-2036.1997.142318000.x – volume: 20 start-page: 8837 year: 2014 ident: e_1_2_11_14_1 article-title: Irritable bowel syndrome and food interaction publication-title: World J Gastroenterol – ident: e_1_2_11_51_1 doi: 10.3390/nu11071566 – ident: e_1_2_11_48_1 doi: 10.3748/wjg.v20.i43.16215 – ident: e_1_2_11_13_1 doi: 10.1159/000051878 – start-page: 29 volume-title: Türkiye Beslenme Rehberi 2015 (TÜBER) year: 2016 ident: e_1_2_11_43_1 – ident: e_1_2_11_38_1 doi: 10.1053/j.gastro.2013.09.046 – ident: e_1_2_11_6_1 doi: 10.14309/00000434-200901001-00002 – ident: e_1_2_11_21_1 doi: 10.1177/14732300080360S101 – volume: 8 start-page: 280 year: 1997 ident: e_1_2_11_26_1 article-title: Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlilik ve Güvenilirlik Çalışması. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale publication-title: Turk psikiyatri dergisi – ident: e_1_2_11_3_1 doi: 10.1097/MCG.0b013e318247157c – volume: 2 start-page: 2 year: 2016 ident: e_1_2_11_25_1 article-title: Psychometric properties of the irritable bowel syndrome quality of life scale in Turkey publication-title: J Hepatol Gastroint Dis – ident: e_1_2_11_12_1 doi: 10.3748/wjg.v20.i34.12144 – ident: e_1_2_11_41_1 doi: 10.1111/nmo.13154 – ident: e_1_2_11_17_1 doi: 10.1097/MOG.0000000000000158 – ident: e_1_2_11_22_1 doi: 10.3390/foods7020013 – ident: e_1_2_11_42_1 doi: 10.3748/wjg.v23.i25.4632 – ident: e_1_2_11_47_1 doi: 10.1007/s00394-021-02620-1 – ident: e_1_2_11_46_1 doi: 10.1007/s00394-019-02074-6 – volume: 5 start-page: 4 year: 2006 ident: e_1_2_11_32_1 article-title: Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı publication-title: Akademik Gastroenteroloji – ident: e_1_2_11_49_1 doi: 10.3920/BM2017.0105 – ident: e_1_2_11_50_1 doi: 10.1016/S1590-8658(00)80021-3 – ident: e_1_2_11_29_1 doi: 10.3109/00365529709011203 – volume: 9 start-page: 131 year: 2016 ident: e_1_2_11_16_1 article-title: Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date publication-title: Clin Exp Gastroenterol – volume: 20 start-page: 398 year: 2016 ident: e_1_2_11_8_1 article-title: Roma IV kriterlerine göre fonksiyonel barsak hastalıklarının yeniden değerlendirilmesi publication-title: GG – ident: e_1_2_11_35_1 doi: 10.1053/j.gastro.2015.07.054 – ident: e_1_2_11_4_1 doi: 10.1016/j.cgh.2012.02.029 – ident: e_1_2_11_19_1 doi: 10.1111/j.1365-277X.2011.01162.x – volume: 18 start-page: 174 year: 2014 ident: e_1_2_11_20_1 article-title: İrritabl bağırsak sendromunun tedavisinde prebiyotik ve probiyotik kullanımı publication-title: GG – ident: e_1_2_11_45_1 doi: 10.1136/gutjnl-2014-307264 – volume: 19 start-page: 172 year: 2015 ident: e_1_2_11_2_1 article-title: İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar publication-title: Güncel Gastroenteroloji – volume: 31 start-page: 51 year: 2007 ident: e_1_2_11_15_1 article-title: Clinical ramifications of malabsorption of fructose and other short‐chain carbohydrates publication-title: Practical Gastroenterol – ident: e_1_2_11_11_1 doi: 10.1016/j.amjmed.2015.01.036 |
SSID | ssj0006100 |
Score | 2.3928711 |
Snippet | Background
The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and... A low fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet may be recommended to apply for 2–8 weeks when symptoms become severe,... The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and probiotics on... BackgroundThe present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and... BACKGROUND: The present study aimed to evaluate the effects of fermented oligosaccharide, disaccharide, monosaccharide and polyols (FODMAP) diet therapy and... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5 |
SubjectTerms | Adult Anxiety depression Depression - etiology Diet diet therapy Dietary supplements dietetics Disaccharides Female females Fermentation FODMAP Diet Food intake hospitals Humans IBS symptom severity Intestine Irritable Bowel Syndrome Lactobacillus rhamnosus Lactose Mannitol Mental depression Mental health Microbiota Middle Aged Monosaccharides Nutrient deficiency Nutrients Nutrition research Nutrition therapy Nutritional status Oligosaccharides people Polyols Prebiotics probiotic Probiotics Quality of Life Sorbitol Statistical analysis Treatment Outcome Womens health Young Adult |
Title | Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjhn.13194 https://www.ncbi.nlm.nih.gov/pubmed/37430435 https://www.proquest.com/docview/2917203007 https://www.proquest.com/docview/2854424746 https://www.proquest.com/docview/3040361224 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxRBEC5CnvKiJvEYc1CKSAR3menuORafVjfLGnAVNZAHYZg-hixOepfsLhJ_iT831T2HRg2Ib3NUNzVMVfVX1TXfADxjJioozKU9xeOyJ4pS97KYHE9zThZTsgGTvst3mkxOxclZfLYBr9pvYWp-iK7g5jzDx2vn4IVc_urk57YfkQE5LtCIJ443f_TxJ3UUwYKw5tljjj82aliFfBdPO_LmWvQHwLyJV_2CM74LX1pV6z6Tr_31SvbV999YHP_zWe7BnQaI4rC2nG3YMHYHdoeWkvCLK3yOvjXU19x3IBjNzIquNSSiFU5bDv9d-HHc8YXjvETCk9j0iLSn4_ejd8MPqN0chdW48NRPjh4aaczs0pUnZGVQzr-ZClsKBTx6-_rTCzq9WJBGy5dYf_555WatZqXxU3V9vDSPRc8mga6yjDT2PpyOjz-_mfSa3z2QnWSJ6wrVEWVPUZyFOlKpq6_QwmlUwrJQMa5jIwaCy4KCCBc6TZVKdKo4NyoMTRYO-APYtHNrHgFGktImkWqlYi1UqgkTMVUaqUVYFITpAjhqX3yuGi5090uOKu9yonOb-zcSwNNOdFETgPxNaL-1nryJAcucUSbMKIaGaQBPutvkvW5LprBmviaZLBaCNBXJ7TKc4ixP3A5oAA9ry-w04QQAQ0K89EDevm5XMT-ZTP3B438X3YMtRhiublLfh83V5docEAZbyUPvbNcFUSrs |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEJ8gPugLKihUEUdjDCbeZbu7_bjEl8PjciCcRiHhxTTt7jZcKL0L3MXgX-Kf6-z2Q1FJjG_9mN1M05nZ38xOfwV4yY2fUpiLOkoEeUemue7EATmeFoIsJuc9nrku33E4Opb7J8HJErxtvoWp-CHagpv1DBevrYPbgvSvXn5adn2yIHkLbksCGjb1Gnz6SR5FwIBVTHvcMsj6Na-Q6-Nphl5fjf6AmNcRq1tyhvfgS6Ns1Wly1l3Ms6769huP4_8-zX1YqbEo9ivjeQBLplyFtX5Jefj5Fb5C1x3qyu6r4A0mZk7Xah7RAscNjf8afN9tKcNxmiNBSqzbRJrT4YfBYf8jajtHWmqcOfYnyxCNNGZyYSsUWWEwm341BTYsCri9t_P5NZ2ez0ijyzdYfQF6ZWctJrlxU7WtvDRPiY5QAm1xGWnsQzge7h69G3XqPz6QqcShbQzVPiVQfhAz7avIllho7TQq5DFTXOjAyJ4UWUpxREgdRUqFOlJCGMWYiVlPPILlclqaDUA_o8xJRlqpQEsVaYJFXOUm05KlKcE6D7abN5-omg7d_pWjSNq06LRM3Bvx4EUrOqs4QP4mtNmYT1KHgcuEUzLMKYyyyIPn7W1yYLsrk5ZmuiCZOJCSNJXhzTKCQq0I7SaoB-uVabaaCMKAjEAvPZAzsJtVTPZHY3fw-N9Fn8Gd0dHhQXKwN37_BO5ygnRVz_omLM8vFuYpQbJ5tuU87weqSi8L |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEB9qBfGLj9bHatVRRCp4RzbJPg4_nV6Pa9WzqIV-EJbdJEsPt7mjvUPqX-Kf6yT70KoF8ds-JmGWnZn8ZjL7W4Cn3IQ5hbmkp0RU9mRe6l4akeNpIchiSj7ghe_yncaTA7l3GB2uwcv2W5iaH6IruDnP8PHaOfhCl786-ZHth2RA8hJcljEhCYeIPvzkjiJcwGqiPe4IZMOGVsi38bRDzy9GfyDM84DVrzjj6_C51bVuNPnSXy2Lvvr2G43jfz7MDbjWIFEc1qZzE9aM3YDNoaUs_PgMn6HvDfVF9w0IRjOzpGsNi2iF05bEfxO-73SE4TgvkQAlNk0i7en4_ejdcB-1myO3Ghee-8nxQyONmZ24-kRRGSzmX02FLYcCbu---vicTo8XpNHpC6y__zxzs1az0vipukZemseip5NAV1pGGnsLDsY7n15Pes3_HshQ0ti1heqQ0qcwSpkOVeIKLLRyGhXzlCkudGTkQIoipygipE4SpWKdKCGMYsykbCBuw7qdW3MXMCwob5KJVirSUiWaQBFXpSm0ZHlOoC6A7fbFZ6ohQ3f_5KiyLik6spl_IwE86UQXNQPI34S2WuvJmiBwmnFKhTkFUZYE8Li7Te7r9mRya-YrkkkjKUlTGV8sIyjQithtgQZwp7bMThNBCJAR5KUH8vZ1sYrZ3mTqD-79u-gjuLI_Gmdvd6dv7sNVTniubljfgvXlyco8IDy2LB56v_sB9Vctug |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+effects+of+the+FODMAP+diet+and+probiotics+on+irritable+bowel+syndrome+%28IBS%29+symptoms%2C+quality+of+life+and+depression+in+women+with+IBS&rft.jtitle=Journal+of+human+nutrition+and+dietetics&rft.au=Ustao%C4%9Flu%2C+Tuba&rft.au=Tek%2C+Nil%C3%BCfer+Acar&rft.au=Y%C4%B1ld%C4%B1r%C4%B1m%2C+Abdullah+Emre&rft.date=2024-02-01&rft.issn=0952-3871&rft.eissn=1365-277X&rft.volume=37&rft.issue=1&rft.spage=5&rft.epage=17&rft_id=info:doi/10.1111%2Fjhn.13194&rft.externalDBID=10.1111%252Fjhn.13194&rft.externalDocID=JHN13194 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3871&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3871&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3871&client=summon |